FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1306912002: Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5316448018 Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5316449014 Lidocaine and naphazoline only product in oromucosal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5316448018 Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5316449014 Lidocaine and naphazoline only product in oromucosal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) Is a Product containing only lidocaine and naphazoline (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) Has manufactured dose form Oromucosal dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Naphazoline (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Lidocaine true Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) Is a Lidocaine- and naphazoline-containing product in oromucosal dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) Is a True Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start